Urine sample contamination marker
most common type of cell seen in the urine sediment
ß-Amyloid (1-42) is a peptide fragment derived from the amyloid precursor protein (APP) and is a critical biomarker in cerebrospinal fluid (CSF) for diagnosing and monitoring Alzheimer’s disease. In a healthy brain, ß-Amyloid (1-42) plays a role in normal neuronal function and synaptic plasticity. However, in Alzheimer’s disease, this peptide aggregates abnormally to form amyloid plaques, one of the hallmark pathological features of the condition. The reference range for ß-Amyloid (1-42) in cerebrospinal fluid (CSF) can vary slightly depending on the laboratory and assay used. However, typical ranges are: Normal Levels: Usually greater than 620 pg/mL (indicative of low risk for Alzheimer's disease). Reduced Levels (indicative of Alzheimer's disease): Less than 620 pg/mL, with lower values correlating with greater amyloid plaque deposition in the brain. Some laboratories or research studies may provide slightly different thresholds, but generally, levels below 620 pg/mL are considered a significant biomarker for Alzheimer’s disease. It's essential to interpret these values in the context of other CSF biomarkers, such as total tau and phosphorylated tau (pTau), for a more accurate diagnosis.
primarily associated with Sjögren’s syndrome
Lactose-digesting gut bacteria
enzyme induced by anaerobic bacteria
Autoantibody associated with SLE or Sjögren’s syndrome.
aid to diagnose autoimmune conditions
aid in diagnosing autoimmune conditions
Autoantibody associated with SLE or Sjögren’s syndrome.
single stranded DNA
involved in water/moisture/wet-damaged building illnesses
The "Stachybotrys chartarum/atra IgE" on an allergy panel is a specific test used to detect an allergic response to Stachybotrys chartarum (also known as Stachybotrys atra), a type of mold often associated with damp and water-damaged buildings. This mold is commonly referred to as "black mold" due to its dark appearance and is known for producing mycotoxins that can be harmful to human health. When people are exposed to Stachybotrys chartarum, either by inhaling spores or through direct contact, their immune system may identify the mold as a threat and produce Immunoglobulin E (IgE) antibodies as a defense mechanism. IgE antibodies are specialized proteins that play a key role in the body's allergic response. The presence of IgE antibodies specific to Stachybotrys chartarum indicates that an individual has developed a sensitivity or allergy to this mold, which can lead to various symptoms upon exposure. These symptoms can range from mild to severe and include respiratory issues (such as coughing, wheezing, and difficulty breathing), nasal congestion, eye irritation, skin rash, and in some cases, more serious allergic reactions. The test is particularly useful for individuals who have experienced unexplained allergic symptoms or respiratory problems, especially if they live or work in environments prone to dampness and mold growth. By measuring the levels of IgE antibodies specific to Stachybotrys chartarum in the blood, healthcare providers can determine if an allergic sensitivity to this mold is contributing to a patient's symptoms. This information can help guide recommendations for reducing exposure to the mold, such as mold remediation in homes or workplaces, and managing symptoms through medication or other treatments. It's important for individuals who are allergic to take steps to minimize their exposure to Stachybotrys chartarum, as ongoing exposure can exacerbate symptoms and negatively impact health. Understanding one's allergic sensitivities is a crucial step in creating a healthier living and working environment and in managing allergic responses effectively.